For research use only. Not for therapeutic Use.
E-3620 is a potent 5-HT3 receptor antagonist. E-3620 can be used for the research of dyskinesi and gastrointestinal motility[1][2].
| Catalog Number | I043299 |
| CAS Number | 151213-86-4 |
| Synonyms | 4-amino-5-chloro-N-[(5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]-2-[(2S)-pent-3-yn-2-yl]oxybenzamide;hydrochloride |
| Molecular Formula | C20H27Cl2N3O2 |
| Purity | ≥95% |
| InChI | InChI=1S/C20H26ClN3O2.ClH/c1-4-5-12(2)26-19-11-18(22)17(21)10-16(19)20(25)23-13-8-14-6-7-15(9-13)24(14)3;/h10-15H,6-9,22H2,1-3H3,(H,23,25);1H/t12-,13?,14+,15?;/m0./s1 |
| InChIKey | GMHMNKHDLXRRGF-YPNZXITFSA-N |
| SMILES | CC#CC(C)OC1=CC(=C(C=C1C(=O)NC2CC3CCC(C2)N3C)Cl)N.Cl |
| Reference | [1]. George Peter Arthur Rice. 5-ht3 receptor antagonists for dyskinesia. CA2231887A1. [2]. Edwin Bernard Villhauer, et al. Combination of dipeptidyl peptidase IV (DPP-IV) inhibitors and compounds modulating 5-HT3 and/or 5-HT4 receptors for therapeutic use. WO2006005613A1. |
